For the Quarter Ending September 2024
North America
In Q3 2024, the North American market for Levofloxacin Hemihydrate experienced a marked increase in pricing, driven by a convergence of several influential factors. The surge in market prices was largely fueled by heightened demand, propelled by improved consumer confidence and early stockpiling in anticipation of the Christmas season.
Additionally, supply chain disruptions significantly impacted availability, particularly the looming threat of port strikes and the ongoing Red Sea crisis, which constrained supply levels and further intensified price increases. The market also grappled with challenges such as blank sailings and adverse weather conditions, which resulted in delays and capacity issues. In the USA, the fluctuations in prices were particularly pronounced, showcasing the most significant changes compared to other regions. The quarter recorded a noteworthy 3% price difference between the first and second halves, indicating a steady upward trend. Although there was an -11% decline from the previous quarter, the quarter-ending price settled at USD 35,190 per metric ton.
Overall, the pricing environment reflected a positive and bullish sentiment, characterized by a consistent upward trajectory in prices throughout the quarter.
Asia Pacific
The third quarter of 2024 has been characterized by a significant upward trend in Levofloxacin Hemihydrate prices in the APAC region. Various factors have influenced this price increase, including strong global demand, especially from major markets like North America and Europe. The surge in demand has been driven by precautionary actions taken by foreign importers to secure larger orders amidst concerns of potential shortages. Additionally, logistical challenges such as disruptions in global shipping routes, particularly in the Red Sea region, have led to increased freight costs, discouraging foreign buyers from placing new orders and contributing to the overall price hike. In China, which has experienced the most significant price changes, the market has seen fluctuating trends influenced by factors like extreme weather events, oversupply, and weak demand. Despite a slight decline from the previous quarter, the overall trend has been positive, with a 4% increase in prices from the first to the second half of the quarter. The quarter-ending price for Levofloxacin Hemihydrate (USP, FDA) FOB Shanghai in China stands at USD 33500/MT, reflecting the ongoing increasing sentiment in the pricing environment.
Europe
In Q3 2024, the pricing of Levofloxacin Hemihydrate in the European region followed a notable upward trajectory, driven by several key factors. One major contributor was the sustained high demand for pharmaceuticals, which was supported by increased consumer purchasing power as inflation rates eased across Europe. This improvement in consumer sentiment spurred stronger demand for medical products, including Levofloxacin Hemihydrate. Additionally, logistical challenges played a significant role in pushing prices higher. The ongoing Red Sea crisis disrupted global shipping routes, intensifying concerns about potential supply chain interruptions. This led market participants to adopt proactive inventory management strategies, aiming to mitigate the risks associated with these disruptions. At the same time, escalating shipping costs and port congestion further constrained the supply chain, contributing to the overall increase in prices. Germany, in particular, experienced the most substantial price fluctuations, reflecting the broader regional trend. The correlation between seasonality and pricing changes was apparent, with a 4% price difference between the first and second half of the quarter. Despite a -12% change from the previous quarter, the quarter-ending price in Germany stood at USD 34,770 per metric ton for Levofloxacin Hemihydrate (USP, FDA) CFR Hamburg, signaling a positive pricing environment amid strong demand and supply constraints.
For the Quarter Ending June 2024
North America
In Q2 2024, the North American market for Levofloxacin Hemihydrate exhibited a mixed trajectory, shaped by a complex interplay of factors influencing the pharmaceutical landscape. The USA, experiencing the most significant price changes, saw an unstable pricing environment with fluctuations throughout the quarter. Prices increased in April and May but decreased in June, influenced by demand dynamics, inventory levels, and global trade activity.
Initially, prices rose due to escalating domestic demand. Consumers remained willing to spend despite cost fatigue, as indicated by stronger retail sales, which boosted the demand for Levofloxacin Hemihydrate. Additionally, shipping challenges in the Red Sea region required longer voyages and increased sailing speeds to counter delays. These adaptations led to higher fuel costs and elevated charter rates, while operational bottlenecks further strained shipping capacity, contributing to the price hikes.
However, by the end of the quarter, prices declined due to a downturn in business sentiment, creating uncertainty over the economy. This lack of confidence affected the pharmaceutical and healthcare industries, leading to subdued demand for Levofloxacin Hemihydrate. The economic pressures were evident, with the price of Levofloxacin Hemihydrate falling by 4% from the previous quarter and showing an 18% difference between the first and second halves of the quarter. The quarter concluded with the price at USD 33,900 per metric ton (USP, FDA) CFR Los Angeles.
Asia Pacific
In Q2 2024, the pricing landscape for Levofloxacin Hemihydrate in the APAC region experienced a mixed trajectory due to various influential factors. Initially, prices increased, driven by increased market confidence compared to the previous month. The manufacturing sector remained in expansion territory, attributed to a surge in demand both domestically and internationally, which facilitated a swift acceleration in output growth. Manufacturers responded to this heightened demand by ramping up their production levels, seeking to capitalize on the influx of new orders. However, prices declined toward the end of the quarter due to an oversupply situation resulting from increased manufacturing capacities, which outpaced the existing demand. The warmer seasonal climate led to a decrease in the prevalence of bacterial illnesses, traditionally treated with Levofloxacin Hemihydrate, thereby reducing overall consumption. Additionally, lower production costs, driven by declining raw material prices and reduced transportation expenses, allowed manufacturers to adjust their pricing strategies downward. External demand remained sluggish as key export markets grappled with high interest rates, impacting consumer spending on pharmaceutical products. The overall sentiment remained negative, as the pricing environment struggled to stabilize amidst these adversities. The quarter ended with the price of Levofloxacin Hemihydrate (USP, FDA) FOB Shanghai at USD 32,000 per metric ton, reflecting the prevailing bearish market conditions.
Europe
In Q2 2024, the pricing landscape for Levofloxacin Hemihydrate in Europe exhibited a mixed trajectory influenced by various factors. Initially, prices rose as consumers were more willing to spend, leading to increased demand for commodities, including Levofloxacin Hemihydrate. However, businesses operating in this optimistic economic climate encountered heightened supply chain costs, driven by escalating wages and high energy prices, which translated into higher prices for goods like Levofloxacin Hemihydrate. In June, prices declined due to sluggish consumer demand, an overstocked market, and falling freight rates. The economic downturn led to reduced illness occurrences, particularly with the onset of warmer weather, further diminishing demand. The central bank's decision to maintain unchanged interest rates contributed to financial strains on consumers, suppressing purchasing activity. Although the global supply chain faced periodic disruptions such as port congestions in Asia and North Europe and adverse weather conditions, it saw some relief from easing geopolitical tensions and seasonal cargo volume spikes. These factors collectively reduced transportation costs, driving prices down further. The seasonality of reduced illness occurrences during warmer months exacerbated the downward pressure on demand. The quarter ended with the price of Levofloxacin Hemihydrate (USP, FDA) CFR Hamburg at USD 33,400 per metric ton, indicating a deeply negative pricing environment.
For the Quarter Ending March 2024
North America
In Q1 2024, the pricing dynamics of Levofloxacin Hemihydrate in the North America region, particularly the USA market, saw a nuanced and diverse range of influences shaping the market landscape. The quarter began with a robust start, driven by positive economic indicators and increased consumer confidence, leading to heightened demand for Levofloxacin Hemihydrate in downstream sectors such as pharmaceuticals and healthcare.
This surge in demand was further fueled by the onset of the cold and flu season, which resulted in an increased prevalence of bacterial infections and a subsequent need for antibiotics. However, this increased demand was met with challenges in the supply chain, as disruptions at vital shipping chokepoints, such as the Red Sea and the Panama Canal, resulted in delays in the delivery of Levofloxacin Hemihydrate and other goods. However, prices experienced a significant decline at the end of quarter due to a downturn in business sentiments, which has cast a shadow of uncertainty over the economy.
The overall trend in pricing for Levofloxacin Hemihydrate in Q1 2024 showed a moderate increase compared to the same quarter last year, driven by factors such as increased consumer spending, seasonality, and disruptions in the supply chain. In conclusion, the final price for Levofloxacin Hemihydrate (USP, FDA) CFR Los Angeles in the USA market for Q1 2024 was USD 41110/MT.
Asia Pacific
In Q1 2024, the pricing dynamics of Levofloxacin Hemihydrate in the APAC region, particularly in China, were subject to a variety of influences. China, where price fluctuations were most pronounced, witnessed a moderate increase in January and February, followed by a decline in March. Several factors contributed to the market situation in China, notably the Spring Festival, which led to factory closures and reduced operations, disrupting production and causing a shortage of the drug. Even after the holiday period, supply remained constrained as production took time to normalize. The scarcity of Levofloxacin Hemihydrate was further compounded by increased demand during the transition from winter to spring and heightened inquiries from major markets such as the USA and Europe. Concerns regarding the stability and efficacy of existing supplies prompted proactive buying behavior among consumers. However, despite this initial surge in demand, prices declined by the end of the quarter. The decline in prices was driven by several factors, including concerns about insufficient domestic demand, despite an increase in economic activity in China following the extended holiday period. Additionally, the absence of inquiries from international markets further exacerbated the downward pressure on prices. It is worth noting that the final quarter's price for Levofloxacin Hemihydrate (USP, FDA) FOB Shanghai in China was stated as USD 39710/MT.
Europe
In Q1 2024, Levofloxacin Hemihydrate prices in Europe displayed a multifaceted pricing dynamic influenced by a variety of factors. The quarter witnessed a gradual increase in prices during January and February, driven by several factors including heightened consumer demand, logistical challenges, and geopolitical tensions. Furthermore, recent data indicating a drop in inflation across the Eurozone, particularly in Germany, suggested an alleviation of financial pressures for consumers. This relief spurred increased demand for Levofloxacin Hemihydrate, consequently pushing prices higher. Additionally, the seasonal nature of bacterial infections during the colder months contributed to increased demand for the medication, further driving up prices. However, prices experienced a decline in March as the market confronted persistently poor performance in new industrial orders. This was characterized by inadequate domestic demand juxtaposed against a relatively high backlog, contributing to the downward trajectory of Levofloxacin Hemihydrate prices in the Europe region. In conclusion, the final quarter's price for Levofloxacin Hemihydrate (USP, FDA) CFR Hamburg in Germany was reported as USD 40910/MT.
For the Quarter Ending December 2023
North America
In the fourth quarter of 2023, the pricing of Levofloxacin Hemihydrate in the North America region experienced significant changes. One of the primary factors that influenced the market was the increased demand from the pharmaceutical and healthcare sectors, which outpaced the available supply. This surge in demand can be attributed to the ongoing consumption activities in these sectors, leading to higher prices for Levofloxacin Hemihydrate.
Additionally, the strong performance of the logistics sector, as indicated by the Logistics Manager’s Index, contributed to the rise in prices. The expansion in warehousing capacity and utilization, as well as the increase in warehousing prices, further propelled the upward trajectory of Levofloxacin Hemihydrate prices. In the United States, which experienced the most significant price changes in the region, Levofloxacin Hemihydrate prices increased by approximately 2.49% in October and continued to rise in November and December. This surge in prices can be attributed to several factors, including the high inflation rate and the strength of the dollar against other currencies, which reduced imported costs and boosted demand for Levofloxacin Hemihydrate from the healthcare and pharmaceutical sectors.
Overall, the pricing of Levofloxacin Hemihydrate in the North America region, particularly in the USA, experienced a significant upward trend in the fourth quarter of 2023. The limited availability of the product and the effects of inflation further supported this upward trajectory. The quarter ending price of Levofloxacin Hemihydrate (USP, FDA) CFR Los Angeles in the USA was USD 39190/MT.
APAC
The fourth quarter of 2023 was characterized by mixed market conditions for Levofloxacin Hemihydrate in the APAC region. One of the primary factors impacting the market was a decline in demand both domestically and internationally. Insufficient market demand, particularly from significant export markets such as Europe and the USA, led to a decrease in new orders for Levofloxacin Hemihydrate. The manufacturing sector in China, the largest market for Levofloxacin Hemihydrate in the APAC region, experienced a contraction in October, further dampening market conditions. This contraction can be attributed to a combination of seasonal factors, such as the eight-day break at the beginning of October, and ongoing challenges in the global economy. Furthermore, the market witnessed ample supply due to a lack of major orders and fierce market competition, leading to market participants offering goods at reduced prices. The decline in Levofloxacin Hemihydrate prices can also be attributed to a decrease in crude oil prices, which resulted in reduced transportation costs and production expenses. In China, the prices of Levofloxacin Hemihydrate experienced a decline in November. This can be attributed to the weakening momentum of the manufacturing sector, as indicated by the contraction in the official manufacturing PMI. The decline in new orders from significant export markets, combined with ample supply and fierce market competition, led to market participants offering products at reduced prices. Overall, the market for Levofloxacin Hemihydrate in the APAC region faced challenging conditions in the fourth quarter of 2023, with weak demand and ample supply. The latest price of Levofloxacin Hemihydrate (USP, FDA) FOB Shanghai in China for the current quarter is USD 38735/MT.
Europe
Levofloxacin Hemihydrate pricing in the Europe region during Q4 2023 was affected by several key factors. Firstly, the market experienced a notable decline in demand due to reduced consumption and diminished consumer spending. This was influenced by a decrease in inflation rates, primarily driven by lower energy costs. Additionally, the European Central Bank's decision to maintain high interest rates constrained consumer spending and dampened overall demand. The Euro's appreciation against the US dollar also contributed to more cost-effective imports and ample supply of Levofloxacin Hemihydrate in the German market. Increased competition among suppliers further facilitated a substantial reduction in prices. In terms of Germany, the largest economy in Europe, Levofloxacin Hemihydrate prices declined in November as a result of decreased demand from end-users and the impact of high interest rates. The market remained bearish, with supply levels ranging from moderate to high. The overall demand was weak, with consumers remaining cautious in their spending. The Euro's appreciation against the US dollar further affected pricing dynamics. The latest price of Levofloxacin Hemihydrate (USP, FDA) CFR Hamburg in Germany for Q4 2023 is USD 40535/MT.
For the Quarter Ending September 2023
North America
The prices of Levofloxacin Hemihydrate experienced a notable decrease of 3.76 percent in July, followed by a slight increase of 1.61 percent in August and a modest rise of 0.43 percent in September. In July, inquiries for new orders and sales fell as domestic and global demand remained weak. The Federal Reserve hiked its key policy interest rate by a quarter percentage point in July, the highest level in 22 years, reducing overall demand in the economy and supporting the downward trend. However, prices rose in August and September due to an increase in energy prices, which boosted overall business expenses and transportation costs, resulting in an increase in Levofloxacin Hemihydrate pricing. Gasoline prices rose as Russia and Saudi Arabia resumed aggressive supply cuts, driving crude oil to a 10-month high of $91 per barrel. Furthermore, imports from major exporting countries such as China dropped, limiting the supply of Levofloxacin Hemihydrate in the US market and driving up prices. Inventory replenishment was a primary priority for market participants, which contributed to the rise in Levofloxacin Hemihydrate pricing.
Asia Pacific
The prices of Levofloxacin Hemihydrate experienced a notable decrease of 2.13 percent in July, followed by a slight increase of 1.36% in August and a modest rise of 0.79% in September. Prices for Levofloxacin Hemihydrate continued to fall in July, as factory activity slowed and demand from downstream sectors fell. The official manufacturing PMI (Purchasing Managers Index) was 49.3 in July, suggesting that factory activity in China contracted for the fourth consecutive month due to reduced overseas orders and insufficient domestic demand. Levofloxacin Hemihydrate prices rose in August and September due to an improvement in end-consumer demand with restricted supply in the market due to the industrial sector's sustained downturn for the fifth consecutive month. Furthermore, China's central bank lowers its key interest rate amid economic concerns, which helps to stimulate market consumption, rising Levofloxacin Hemihydrate costs in China. China's manufacturing purchasing managers' index (PMI) gently soared back into the expanding zone in September, exposing the restoration of industry activity and signaling a promising economic revival within the country.
Europe
The prices of Levofloxacin Hemihydrate displayed a noteworthy decrease of 3.52 percent in July, followed by a modest increase of 1.53% and 0.82% in the months of August and September, respectively. Prices for levofloxacin hemihydrate fell in July due to a slowdown in business activity and a fall in downstream sector demand. The steep drop in demand for goods can be linked to a number of factors, including customer hesitancy, destocking, and increasing borrowing rates, as well as tightening market circumstances and economic and geopolitical uncertainty. Prices increased in August and September as a result of continuous inflation, rising interest rates, and the energy crisis. In August, the German inflation rate was +6.1%, as measured by the year-on-year change in the consumer price index (CPI). Food and energy prices have grown faster than average inflation, contributing to high inflation. Prices for energy products increased 8.3% year on year, following a 5.7% increase in July. Businesses' expenses for maintaining APIs (Active Pharmaceutical Ingredients) rise as a result of continual high inflation, contributing to higher Levofloxacin Hemihydrate prices in Germany.
For the Quarter Ending June 2023
North America
In the US, the prices of Levofloxacin Hemihydrate increased by 1.70 percent in June from the levels noticed in April. The US manufacturing PMI (Purchasing Managers Index) dropped to 46.3 in June, from 48.4 in May and 47.1 in April, suggesting limited inventories among market suppliers and traders accompanied by delays in delivery by suppliers to meet consumer demand, which supported the upward trend of prices of levofloxacin hemihydrate. Additionally, rising market sentiment was a result of an increase in consumer interest and a shortage of supply, which further compelled the traders to raise their quotations and concentrate on the restocking procedures. The consumer price index (CPI), an indicator of inflation, increased by 0.2% in June compared to 0.1% in May, suggesting inflation has slowed down in June due to a hike in interest rates by US Federal Reserve. Although the inflation rate was down, prices remained on the higher side, indicating more rate hikes were possible in the third quarter. Apart from that, the import momentum persisted at a consistent level, supporting the Levofloxacin Hemihydrate market trajectory in the second quarter.
Asia Pacific
In China, the prices of Levofloxacin Hemihydrate increased by 0.99 percent in June from the levels noticed in April. Levofloxacin Hemihydrate prices remained on the higher side in the second quarter due to increased demand from end consumers and fewer inventories among market providers. Moreover, higher upstream costs and restocking of inventories with fresh stock in order to cater to future demand further supported the Levofloxacin Hemihydrate market to remain strong. The official manufacturing Purchasing Managers' Index of China settled at 49.0 in June, from 48.8 in May and 49.2 in April, pointing out that factory activity had decreased for the third consecutive month resulting in less production activity. This caused a shortage of inventories in their warehouses amid a positive demand outlook, keeping the price on the higher side. Apart from that, the ongoing operational activity of plants coupled with rising inquiries from importers and traders resulted in higher production costs in the domestic market that further supported increased prices of levofloxacin hemihydrate across the Chinese market.
Europe
In Germany, the prices of Levofloxacin Hemihydrate increased by 2.04 percent in June from the levels noticed in April. Rising domestic demand coupled with overall supplies among the domestic merchants was the main driver of higher price realization for Levofloxacin Hemihydrate in the second quarter. Moreover, the market in Germany is further supported by new production in exporting nations in response to demand and high energy prices. Germany's manufacturing Purchasing Managers Index (PMI) fell to 41 in June, from 43.2 in May and 44.5 in April, reflecting lower business activity, fewer inventories among market traders and suppliers, and delays in shipments to meet demand, which led to higher prices for levofloxacin hemihydrate. Additionally, increasing demand from the end-use sector is further driving the upward trend in the price of levofloxacin hemihydrate. In addition, inflation increased by 6.4% in June, and energy prices rose by 3%, leading to higher costs for businesses relying on APIs (Active pharmaceutical ingredients), subsequently leading to higher prices of Levofloxacin hemihydrate.
For the Quarter Ending March 2023
North America
In the first quarter of 2023, the price of Levofloxacin Hemihydrate saw an upsurged trend. However, until February, the prices continued to grow on a positive note but declined at the same rate as the first quarter concluded in March 2023. Increase in domestic demand with limited supplies among market players, the price of Levofloxacin Hemihydrate has been on the rise until February 2023. By the termination of the first quarter, the consumer demand highlighted a weaker trend, due to which traders and local suppliers focused on placing the orders according to necessities. In addition to that, a slowdown in trade activity has additionally kept the market trend of Levofloxacin Hemihydrate in a downward direction. Overall, the cost of Levofloxacin Hemihydrate in the United States during the month of March was constructed at USD 66015/MT.
Asia Pacific
Prices for Levofloxacin Hemihydrate throughout the first quarter of 2023 showcased an inclined market trend. In early January, the market sentiments somewhat improved in China during the holiday-shortened month of January, primarily on account of improved demands following the Lunar New Year because both consumption and production increased significantly as the government abandoned its zero-COVID policy. A rise in domestic demand and inquiries from the international market further supported the overall market trend of Levofloxacin Hemihydrate until the mid of the first quarter of 2023. whereas, as March 2023 commenced, the prices of Levofloxacin Hemihydrate declined but stably, which was supported by a drop in domestic demand from downstream sectors coupled with sufficient stockpiles that can meet the overall necessities. With this, the prices of Levofloxacin Hemihydrate were settled at USD 63105/MT in China.
Europe
The prices of Levofloxacin Hemihydrate commenced the first half of the first quarter of 2023 on a bullish note on the back of a rise in orders from end-user sectors but ended on a tremendously bearish note. In early January, German consumer prices increased and continued to rise until the mid of the first quarter as a result of lowering inflation and decreased energy costs, which progressively boosted consumer confidence. Also, the market has started to show signals of strength in support of an improvement in the flow of commerce from China to Europe in comparison to the previous month, which has encouraged the overall market sentiments of Levofloxacin Hemihydrate in the German market. Nevertheless, orders from end-user industries were reduced, and the suppliers were left with enough inventories among themselves, keeping the market feeble towards the termination of the first quarter. With this, the prices of Levofloxacin Hemihydrate were assembled at USD 67145/MT in Germany.
For the Quarter Ending December 2022
North America
Throughout the last quarter of 2022, the North American region, particularly the United States market, showed declining pricing sentiments for Levofloxacin Hemihydrate. At the start of the fourth quarter, prices stayed relatively steady because demand inclined positively compared to the previous month. The different reasons that have affected the market for practically all commodities, including Levofloxacin Hemihydrate, are still closely monitored by market participants as fluctuating prices feared them for their losses. Until November, the prices held on the upper end due to lessening domestic market's overall supplies and healthy demand. With this, the price of Levofloxacin Hemihydrate was significantly demonstrated at USD 67220/MT CFR Los Angeles. After mod q-4 the prices of Levofloxacin Hemihydrate dropped considerably with the closure of the local market on account of New-year breaks.
Asia Pacific
With the end of the Final Quarter of 2022, Levofloxacin Hemihydrate prices in the Asia Pacific area, particularly in China, showed a considerable decline. Until November, China's biggest challenge was handling backed-up logistics on the main trade routes to North America and Europe due to restrictions on the export of all goods, including Levofloxacin Hemihydrate, which also had an impact on the price trends of this drug. In November, in the mid of the fourth quarter, Levofloxacin Hemihydrate prices were set at USD 61770/MT. Following the end of 2022, downstream demand and traders' quotations declined significantly, keeping the prices of Levofloxacin Hemihydrate on the south side.
Europe
During the fourth quarter of 2022, the prices of Levofloxacin Hemihydrate plummeted in the European region. October month witnessed a steadily incremented trajectory as end-user demand from the pharmaceutical sector for Levofloxacin Hemihydrate increased compared to the previous month, i.e., September. Until November, the prices inclined considerably with the settlement of USD 72580/MT CFR Hamburg in Germany and ended in December on the lower side. Furthermore, Levofloxacin Hemihydrate's price trend in November was additionally supported by the ease in supply chain interruption and shipping costs. However, as growing energy prices began to level down at the end of 2022, inflation in Europe declined in December for the second consecutive month, providing somewhat comfort in the prices of Levofloxacin Hemihydrate. On top of that, due to a decline in international orders, notably from exporting nations like China, demand decreased in December, positively supporting the market sentiments.
For the Quarter Ending September 2022
North America
During the third Quarter of 2022, the prices of Levofloxacin Hemihydrate in the North American Region witnessed mixed sentiments. At the onset of the first half of Q3, the prices went down stably with sufficient supplies from the domestic merchants. Further, the prices rose significantly in the mid of q3 owing to increased downstream demand from the end-user sector and enough stocks with the suppliers to meet the overall demand side. Also, affected trading momentum from exporting countries impacted the market sentiments toward Levofloxacin Hemihydrate. Moreover, towards the termination of Q3, the prices showcased a decremented state again with the settlement of USD 63860/MT CFR Los Angeles in the united states.
Asia Pacific
During the third Quarter of 2022, the prices of Levofloxacin Hemihydrate in the APAC region witnessed a fluctuating trend owing to variable downstream demand and the supply side witness. In the first two months of q3, the prices rose significantly, leading to the shortage of stocks with the suppliers, which propelled them to increase their quotations. Additionally, disrupted trading activities leading to delayed shipments and rerouting momentum were another factor that supported the market sentiments of Levofloxacin Hemihydrate in the region. Furthermore, towards the termination of q3, the prices decreased considerably owing to weaker demand and enough supplies with the settlement of USD 56750/MT FOB Shanghai.
Europe
The European region witnessed similar market sentiments in the prices for Levofloxacin Hemihydrate as the APAC region, owing to heightened downstream demand in the market. Also, due to consistent offtakes from the domestic market amid rising input costs, the prices of Levofloxacin Hemihydrate inclined. Across Europe, rising energy costs due to the Russia-Ukraine conflict and the rerouting activities kept the market on the higher side. Furthermore, delayed exports from China due to Covid restrictions on transportation led to low inventories in the regional market till the mid of q3. Towards the termination of q3, the prices for Levofloxacin Hemihydrate went down significantly owing to decremented demand for sufficient supplies with the suppliers. The prices witnessed in September for Levofloxacin Hemihydrate settled at USD 67170/MT CFR Hamburg.
For the Quarter Ending June 2022
North America
During the second quarter of 2022, the North American region showcased an upsurged pricing sentiment for levofloxacin hemihydrate backed by enhanced downstream demand from end-user enterprises and trading activities in the regional market. Moreover, higher feedstock prices in the market augmented downstream Levofloxacin hemihydrate prices. Rising freight charges and shipment activities also added another value to the prices for Levofloxacin hemihydrate as the commodities are majorly exported from APAC countries. Furthermore, the surging demand caused a shortage of downstream end-products in the market, which caused difficulties for the trader to meet the requirements. Towards the termination of second quarter the prices for Levofloxacin Hemihydrate were settled at USD 62948/MT CFR Los Angeles.
Asia Pacific
APAC region witnessed an upward pricing trajectory for Levofloxacin Hemihydrate during the second quarter of 2022, owing to extended downstream demand and supply disruption in the regional market. Due to unprecedently rising covid cases and trade disruption, levofloxacin hemihydrate prices increased significantly. Additionally, downstream demand caused a shortage of products in the overall domestic and regional market due to delayed shipments. Also, the continual war between Russia-Ukraine led to heightened Feedstock and crude oil prices which augmented the price movement of levofloxacin hemihydrate in the market. Towards the termination of second quarter the prices for Levofloxacin Hemihydrate were settled at USD 56680/MT FOB Shanghai.
Europe
The European region witnessed similar market sentiments in the prices for Levofloxacin Hemihydrate as the North American region, owing to heightened feedstock costs in the market. Also, with respect to feedstock prices in the market, the production activity was heightened, resulting in a higher cost of Levofloxacin hemihydrate. Additionally, surging freight charges due to a shortage of shipments and rerouting activities amid the Russian-Ukraine war caused the prices to spike high of Levofloxacin Hemihydrate. Furthermore, higher downstream demand resulted in a shortage of Stock with the suppliers in the mar, causing difficulty for the manufacturers to meet the rising requirements of customers from the domestic and regional markets. Towards the termination of second quarter the prices for Levofloxacin Hemihydrate were settled at USD 64640/MT CFR Hamburg.
